{"title":"Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer","path":"/2026/02/06/kelun-biotech-announces-fourth-indication-for-sacituzumab-tirumotecan-sac-tmt-approved-by-nmpa-in-hr-her2-breast-cancer/","site":"https://laotiantimes.com","atUri":"at://did:plc:svcthvzunxmjidtlw23zva6n/site.standard.document/3me6lv2pgsn22","publishedAt":"2026-02-06T09:00:00Z","tags":"Cision PR Newswire"}